Lina_S

About SIOG Head Office

This author has not yet filled in any details.
So far SIOG Head Office has created 420 blog entries.

Tumor marker usage and medical care costs among older early-stage breast cancer survivors

SIOG Head Office2021-07-29T22:38:05+02:00

Ramsey SD, Henry NL, Gralow JR, Mirick DK, Barlow W, Etzioni R, Mummy D, Thariani R, Veenstra DL. J Clin Oncol. 2015 Jan 10;33(2):149-55. doi: 10.1200/JCO.2014.55.5409. Epub 2014 Oct 20. (Pubmed)

Tumor marker usage and medical care costs among older early-stage breast cancer survivorsSIOG Head Office2021-07-29T22:38:05+02:00

Polypharmacy: Geriatric Oncology Evaluation Should Become Mainstream

SIOG Head Office2021-07-29T22:38:05+02:00

Lichtman SM. J Clin Oncol. 2015 Mar 23. pii: JCO.2014.60.3548. [Epub ahead of print] (Journal of Clinical Oncology)

Polypharmacy: Geriatric Oncology Evaluation Should Become MainstreamSIOG Head Office2021-07-29T22:38:05+02:00

Ageism in the undertreatment of high-risk prostate cancer: how long will clinical practice patterns resist the weight of evidence?

SIOG Head Office2021-07-29T22:38:06+02:00

Shumway DA, Hamstra DA. J Clin Oncol. 2015 Mar 1;33(7):676-8. doi: 10.1200/JCO.2014.59.4093. Epub 2015 Jan 5. (Journal of Clinical Oncology)

Ageism in the undertreatment of high-risk prostate cancer: how long will clinical practice patterns resist the weight of evidence?SIOG Head Office2021-07-29T22:38:06+02:00

Prognostic Significance of NPM1 Mutations in the Absence of FLT3-Internal Tandem Duplication in Older Patients With Acute Myeloid Leukemia: A SWOG and UK National Cancer Research Institute/Medical Research Council Report.

SIOG Head Office2021-07-29T22:38:06+02:00

Ostronoff F, Othus M, Lazenby M, Estey E, Appelbaum FR, Evans A, Godwin J, Gilkes A, Kopecky KJ, Burnett A, List AF, Fang M, Oehler VG, Petersdorf SH, Pogosova-Agadjanyan EL, Radich JP, Willman CL, Meshinchi S, Stirewalt DL. J Clin Oncol. 2015 Apr 1;33(10):1157-64. doi: 10.1200/JCO.2014.58.0571. Epub 2015 Feb 23. (Pubmed)

Prognostic Significance of NPM1 Mutations in the Absence of FLT3-Internal Tandem Duplication in Older Patients With Acute Myeloid Leukemia: A SWOG and UK National Cancer Research Institute/Medical Research Council Report.SIOG Head Office2021-07-29T22:38:06+02:00

A review of the management of elderly patients with non-small-cell lung cancer.

SIOG Head Office2021-07-29T22:38:06+02:00

Blanco R, Maestu I, de la Torre MG, Cassinello A, Nuñez I. Ann Oncol. 2015 Mar;26(3):451-63. doi: 10.1093/annonc/mdu268. Epub 2014 Jul 24. (Annals of Oncology)

A review of the management of elderly patients with non-small-cell lung cancer.SIOG Head Office2021-07-29T22:38:06+02:00

Evaluation of a pharmacist-led medication assessment used to identify prevalence of and associations with polypharmacy and potentially inappropriate medication use among ambulatory senior adults with cancer.

SIOG Head Office2021-07-29T22:38:06+02:00

Nightingale G, Hajjar E, Swartz K, Andrel-Sendecki J, Chapman A. J Clin Oncol. 2015 May 1;33(13):1453-9. doi: 10.1200/JCO.2014.58.7550. Epub 2015 Mar 23. (Pubmed)

Evaluation of a pharmacist-led medication assessment used to identify prevalence of and associations with polypharmacy and potentially inappropriate medication use among ambulatory senior adults with cancer.SIOG Head Office2021-07-29T22:38:06+02:00

Screening for predictors of adverse outcome in onco-geriatric surgical patients: A multicenter prospective cohort study.

SIOG Head Office2021-07-29T22:38:06+02:00

Huisman MG, Audisio RA, Ugolini G, Montroni I, Vigano A, Spiliotis J, Stabilini C, de Liguori Carino N, Farinella E, Stanojevic G, Veering BT, Reed MW, Somasundar PS, de Bock GH, van Leeuwen BL. Eur J Surg Oncol. 2015 Apr 13. pii: S0748-7983(15)00375-3. doi: 10.1016/j.ejso.2015.02.018. [Epub ahead of print] (Pubmed)

Screening for predictors of adverse outcome in onco-geriatric surgical patients: A multicenter prospective cohort study.SIOG Head Office2021-07-29T22:38:06+02:00

Impact of age and medical comorbidity on adjuvant treatment outcomes for stage III colon cancer: a pooled analysis of individual patient data from four randomized, controlled trials.

SIOG Head Office2021-07-29T22:38:06+02:00

Haller DG, O'Connell MJ, Cartwright TH, Twelves CJ, McKenna EF, Sun W, Saif MW, Lee S, Yothers G, Schmoll HJ. Ann Oncol. 2015 Apr;26(4):715-24. doi: 10.1093/annonc/mdv003. Epub 2015 Jan 16. (Pubmed)

Impact of age and medical comorbidity on adjuvant treatment outcomes for stage III colon cancer: a pooled analysis of individual patient data from four randomized, controlled trials.SIOG Head Office2021-07-29T22:38:06+02:00

Different adjuvant chemotherapy regimens in older breast cancer patients?

SIOG Head Office2021-07-29T22:38:06+02:00

Wildiers H., Brain E. Ann Oncol (2015) 26 (4): 613-615. doi: 10.1093/annonc/mdv015 First published online: January 18, 2015 (Annals of Oncology)

Different adjuvant chemotherapy regimens in older breast cancer patients?SIOG Head Office2021-07-29T22:38:06+02:00

Adjuvant chemotherapy for elderly patients with stage I non-small-cell lung cancer ≥4 cm in size: an SEER-Medicare analysis

SIOG Head Office2021-07-29T22:38:06+02:00

Malhotra J, Mhango G, Gomez JE, Smith C, Galsky MD, Strauss GM, Wisnivesky JP. Ann Oncol. 2015 Apr;26(4):768-73. doi: 10.1093/annonc/mdv008. Epub 2015 Jan 18. (Pubmed)

Adjuvant chemotherapy for elderly patients with stage I non-small-cell lung cancer ≥4 cm in size: an SEER-Medicare analysisSIOG Head Office2021-07-29T22:38:06+02:00

Previous 363738 Next

Powered by K.I.T. Group – Crafted for Excellence